Login

MM MM

Multiple Myeloma Home

REVLIMID^® (lenalidomide)
Clinical Evidence Resources PBS

POMALYST^® (pomalidomide)
Clinical Evidence Resources PBS

THALOMID^® (thalidomide)
Resources

EMPLICITI^® (elotuzumab)
Clinical Evidence Resources PBS
AML
PBS
Information

REVLIMID^® (lenalidomide) POMALYST^® (pomalidomide) EMPLICITI^® (elotuzumab) ONUREG^® (azacitidine)
Resources
Product
Information

REVLIMID^® (lenalidomide) POMALYST^® (pomalidomide) EMPLICITI^® (elotuzumab) ONUREG^® (azacitidine)

Failed

Loading...

Contact Us Legal Notice i-access^® Program Privacy Policy Modern Slavery Statement © 2025 Bristol-Myers Squibb

REVLIMID^®, POMALYST^®, ONUREG^® and EMPLICITI^® are registered trademarks of Bristol Myers Squibb Company.
Level 2, 4 Nexus Court, Mulgrave VIC 3170.

2003-AU-2400004.
Date of preparation: October 2024.

5 languages available

Arabic Chinese English Italian Greek Vietnamese

5 languages available

Arabic Chinese English Italian Greek Vietnamese